Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemiaRonan Swords, Jennifer S. Carew, Kevin R. Kelly et al.|Blood|2010Cited by 278
Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin LevelsDevalingam Mahalingam, Steffan T. Nawrocki, Francis J. Giles et al.|Clinical Cancer Research|2009Cited by 121
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinibKevin R. Kelly, Jennifer S. Carew, Jeffrey Ecsedy et al.|Journal of Cellular and Molecular Medicine|2010Cited by 73
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinomaDevalingam Mahalingam, Steffan T. Nawrocki, Claudia M. Espitia et al.|British Journal of Cancer|2011Cited by 28
The Aurora Kinase Inhibitor MLN8237 Has Potent Anticancer Activity in CML and Ph+ ALL Models and Significantly Increases the Efficacy of NilotinibSteffan T. Nawrocki, Jennifer S. Carew, Ernest Medina et al.|Blood|2008Cited by 6